Hyperbaric oxygen therapy (HBOT) doesn’t have a single success rate. Its effectiveness varies dramatically depending on the condition being treated, ranging from near-universal symptom improvement for some radiation injuries to uncertain benefits for others like sudden hearing loss. The therapy is FDA-cleared and Medicare-covered for about 15 specific conditions, and within those approved uses, the evidence is generally strong.
A standard course involves breathing pure oxygen inside a pressurized chamber at 1.5 to 2.5 times normal atmospheric pressure, typically for 60 to 90 minutes per session. Most protocols call for 10 to 20 sessions, though some conditions require more. Here’s what the research shows for the major conditions where HBOT is used.
Diabetic Foot Ulcers
Diabetic foot wounds are one of the most common reasons people are referred for HBOT, and the evidence here is solid. A meta-analysis of 11 controlled trials with 644 patients found that HBOT significantly improved complete wound healing compared to standard treatment alone. It also reduced the risk of major amputation by about 40%.
These results apply to serious wounds, specifically Wagner grade III or higher, meaning ulcers that have penetrated deep into tissue or bone. HBOT is typically added only after standard wound care has failed, not as a first-line treatment. Smoking history matters here: patients with more than 10 pack-years of smoking needed 8 to 14 additional treatment sessions to see comparable healing, adding $4,000 to $7,000 in costs per patient.
Radiation Tissue Injury
Late radiation injury is one of the conditions where HBOT performs best. Radiation from cancer treatment can damage blood vessels and tissues months or years later, causing chronic bleeding, pain, and tissue breakdown. The bladder is a common site, producing a condition called hemorrhagic cystitis.
In a study of 38 patients with severe radiation-induced bladder bleeding treated with HBOT alone, 86.8% had a complete response and the remaining 13.2% had partial response with marked improvement. That’s a 100% overall response rate. HBOT is also approved for radiation damage to bone (osteoradionecrosis) and soft tissue, where it works by stimulating new blood vessel growth in oxygen-starved tissue.
Carbon Monoxide Poisoning
HBOT is the standard emergency treatment for serious carbon monoxide poisoning, and the key benefit isn’t just faster recovery. It’s the prevention of delayed brain damage that can appear days or weeks after the initial poisoning. Patients treated with regular oxygen instead of HBOT had roughly five times the risk of developing these delayed neurological problems. The odds ratio was 8.5, meaning the risk was dramatically higher without hyperbaric treatment.
This is one of the clearest use cases for HBOT because carbon monoxide binds to hemoglobin far more tightly than oxygen does. Breathing pure oxygen at high pressure forces it out of the bloodstream much faster than normal oxygen therapy can.
Decompression Sickness
For divers with decompression sickness (“the bends”), HBOT is the definitive treatment rather than an adjunctive one. The therapy works by shrinking nitrogen bubbles trapped in blood and tissues while flooding the body with oxygen. Timing matters significantly: patients treated within 24 hours were more likely to need only a single recompression session, while those with longer delays (median 34 hours) typically required multiple treatments.
Exact resolution percentages vary by severity, but HBOT has been the standard of care for decompression illness since the mid-20th century, and no alternative treatment exists.
Chronic Bone Infections
Chronic refractory osteomyelitis, a bone infection that won’t clear with antibiotics and surgery alone, responds well to HBOT as an add-on treatment. Remission rates of 81% to 85% at two to three years have been reported. For a condition defined by its failure to respond to conventional treatment, that’s a meaningful success rate. The high-oxygen environment helps white blood cells kill bacteria more effectively and enhances the penetration of certain antibiotics.
Severe Crush Injuries and Limb Salvage
When used alongside surgery for severe limb injuries, HBOT significantly improves tissue survival. In one controlled trial, complete wound healing without tissue death occurred in 94% of patients who received HBOT compared to 56% in the control group. Another study achieved complete healing in 87% of patients with severe lower limb soft tissue injuries. The therapy reduces swelling, fights infection, and keeps borderline tissue alive long enough for the body’s repair processes to catch up.
Sudden Hearing Loss
This is where HBOT’s reputation gets murkier. Sudden sensorineural hearing loss is sometimes treated with HBOT alongside steroids, but the evidence is mixed. A study of 113 patients with severe to profound hearing loss found that 71% achieved at least some recovery, but there was no notable difference in outcomes between patients who received HBOT and those who didn’t. The one exception: diabetic patients showed significantly better hearing improvement with HBOT compared to the control group.
Pressure levels during treatment seem to matter. Patients treated at 2.5 times atmospheric pressure had better results than those at 1.5 times, particularly at lower sound frequencies. But overall, the evidence doesn’t strongly support HBOT as a game-changer for hearing loss in the general population.
What Affects Your Odds of Success
Several factors influence how well HBOT works for any given patient. Smoking is the most well-documented one. In a study of 469 patients with diabetic wounds, smoking history was a statistically significant predictor of treatment outcome. Smokers needed substantially more sessions and had slower healing. Duration of diabetes, the severity of the wound, and baseline oxygen levels in the tissue also predicted results.
Timing plays a role across nearly every condition. Carbon monoxide poisoning responds best when treated quickly. Decompression sickness resolves faster with earlier intervention. For diabetic wounds, HBOT is typically a later-stage option after standard care fails, so patients arrive with more advanced disease, which naturally lowers the headline success numbers compared to conditions treated earlier.
Conditions Medicare Covers
Medicare Part B covers HBOT for 15 specific conditions, which gives a practical picture of where the evidence is strong enough to justify reimbursement. The full list includes:
- Carbon monoxide and cyanide poisoning
- Decompression sickness and gas embolism
- Gas gangrene
- Crush injuries and severed limbs
- Severe soft tissue infections
- Acute peripheral blood vessel insufficiency
- Compromised skin grafts
- Chronic bone infections unresponsive to other treatment
- Radiation damage to bone and soft tissue
- Diabetic lower extremity wounds (Wagner grade III or higher, after standard care has failed)
- Actinomycosis unresponsive to antibiotics and surgery
HBOT is marketed for many conditions beyond this list, including traumatic brain injury, autism, anti-aging, and athletic performance. None of those uses are supported by the level of evidence behind the approved indications, and insurance won’t cover them. The gap between what HBOT clinics advertise and what the data supports is wide, so the specific condition you’re considering it for matters more than any overall success rate.